Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2011 1
2012 1
2013 2
2015 1
2017 1
2021 2
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model.
Barsheshet Y, Voloshin T, Brant B, Cohen G, Koren L, Blatt R, Cahal S, Haj Khalil T, Zemer Tov E, Paz R, Klein-Goldberg A, Tempel-Brami C, Jacobovitch S, Volodin A, Kan T, Koltun B, David C, Haber A, Giladi M, Weinberg U, Palti Y. Barsheshet Y, et al. Among authors: haber a. Int J Mol Sci. 2022 Nov 15;23(22):14073. doi: 10.3390/ijms232214073. Int J Mol Sci. 2022. PMID: 36430552 Free PMC article.
L-glutamine Induces Expression of Listeria monocytogenes Virulence Genes.
Haber A, Friedman S, Lobel L, Burg-Golani T, Sigal N, Rose J, Livnat-Levanon N, Lewinson O, Herskovits AA. Haber A, et al. PLoS Pathog. 2017 Jan 23;13(1):e1006161. doi: 10.1371/journal.ppat.1006161. eCollection 2017 Jan. PLoS Pathog. 2017. PMID: 28114430 Free PMC article.
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo.
Davidi S, Jacobovitch S, Shteingauz A, Martinez-Conde A, Braten O, Tempel-Brami C, Zeevi E, Frechtel-Gerzi R, Ene H, Dor-On E, Voloshin T, Tzchori I, Haber A, Giladi M, Kinzel A, Weinberg U, Palti Y. Davidi S, et al. Among authors: haber a. Cancers (Basel). 2022 Jun 15;14(12):2959. doi: 10.3390/cancers14122959. Cancers (Basel). 2022. PMID: 35740624 Free PMC article.
In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso.
Blatt R, Davidi S, Munster M, Shteingauz A, Cahal S, Zeidan A, Marciano T, Bomzon Z, Haber A, Giladi M, Weinberg U, Kinzel A, Palti Y. Blatt R, et al. Among authors: haber a. Front Oncol. 2021 Jun 24;11:670809. doi: 10.3389/fonc.2021.670809. eCollection 2021. Front Oncol. 2021. PMID: 34249709 Free PMC article.
Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study.
Abutbul A, Mumblat H, Porat Y, Friedman N, Atari N, Sharabi S, Nama A, Mugahed W, Kessler A, Kolben Y, Shamir RR, Manzur D, Farber O, Bosch L, Lavy-Shahaf G, Dor-On E, Haber A, Giladi M, Weinberg U, Palti Y, Mardor Y, Mandelboim M. Abutbul A, et al. Among authors: haber a. Front Microbiol. 2023 Nov 29;14:1296558. doi: 10.3389/fmicb.2023.1296558. eCollection 2023. Front Microbiol. 2023. PMID: 38094629 Free PMC article.
Bioavailability of calcium in an enriched postbiotic system compared to calcium citrate in healthy postmenopausal females; A randomized, double-blind, comparator-controlled, crossover study.
Friling M, Haber A, Furman-Assaf S, Israel D, Harari G, Evans M, Crowley DC, Ouwehand AC, Ivanir E. Friling M, et al. Among authors: haber a. Front Nutr. 2023 Mar 15;10:1073622. doi: 10.3389/fnut.2023.1073622. eCollection 2023. Front Nutr. 2023. PMID: 37006928 Free PMC article.
16 results